Enter your login e-mail to the account
Search
- Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Cystic fibrosis in adults
MUDr. Libor Fila, Ph.D.
(4/2015, Review articles )
- RNA interferencia – nový nástroj génovej terapie
Bc. Branislav Kusenda, RNDr. Šárka Pospíšilová, Ph.D.
(2/2006, Main topic ) - Chlamydophila pneumoniae and multiple sclerosis
MUDr. Jan Galský, Ph.D., MBA
(1/2013, From the boundary of neurology ) - Autoimmune meningoencephalitis associated with anti‑GFAP antibodies – a case study
MUDr. Hana Mojžišová, MUDr. Martin Elišák, Ph.D., RNDr. Jitka Hanzalová, MUDr. David Krýsl, Ph.D., Prof. MUDr. Petr Marusič, Ph.D.
(2/2023, Case reports ) - MOYAMOYA ONEMOCNĚNÍ
MUDr. David Goldemund
(2/2008, Case reports ) - Myotonic dystrophies
MUDr. Radim Mazanec, Ph.D., Mgr. Zuzana Mušová, Ph.D.
(4/2012, Main topic ) - Basic cerebrospinal fluid test in diagnosing central nervous system involvement
doc. MUDr. Pavel Adam, CSc., MUDr. Ondřej Sobek, CSc., RNDr. Ing. Petr Kelbich, MUDr. Martina Koudelková, MUDr. Jan Procházka, Eva Hanuljaková, MUDr. Radka Válková
(5/2009, Main topic )
- Advances in meningococcal vaccination
MUDr. Pavla Křížová, CSc.
(S1/2012, Review and original articles ) - Molecular genetics for physicians
prof. MUDr. László Kovács, DrSc., MPH, doc. MUDr. Denisa Ilenčíková, PhD., Mgr. Michaela Čižmárová
(6/2013, Review articles ) - NEW PAEDIATRIC INDICATIONS FOR GROWTH HORMONE THERAPY IN CZECH REPUBLIC
doc. MUDr. Jiřina Zapletalová, Ph.D. a kol.
(1/2006, Review articles )
- The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Mechanizmy imunitného systému v boji proti nádorom a príčiny ich zlyhania
Doc. MUDr. Mária Bucová, CSc., MUDr. Kristína Klučková, Prof. MUDr. Milan Buc, DrSc.
(2/2018, Main topic ) - Increased production of HE4 by tumour tissues and its importance of measurement in patients with malignant tumours
MUDr. Jaroslav Weissensteiner, doc. Mgr. Eva Babušíková, PhD.
(1/2015, Review articles ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Hereditary oncological syndromes: DNA mutations and diagnostic techniques of genetic testing
RNDr. Michal Konečný, PhD., RNDr. Katarína Závodná, PhD., Mgr. Ján Markus, PhD., Mgr. Lenka Dolešová, prof. RNDr. Vanda Repiská, PhD., doc. MUDr.aniel Böhmer, PhD.1
(2/2015, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Chronic lymphocytic leukemia – genetics
MUDr. Lucia Copáková, RNDr. Michaela Leitnerová, RNDr. Barbora Piačková
(2/2014, Oncohematology Review ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )